Himanshu Nagar

1.1k total citations
71 papers, 728 citations indexed

About

Himanshu Nagar is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Cancer Research. According to data from OpenAlex, Himanshu Nagar has authored 71 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Pulmonary and Respiratory Medicine, 20 papers in Radiation and 18 papers in Cancer Research. Recurrent topics in Himanshu Nagar's work include Prostate Cancer Diagnosis and Treatment (31 papers), Prostate Cancer Treatment and Research (28 papers) and Advanced Radiotherapy Techniques (20 papers). Himanshu Nagar is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (31 papers), Prostate Cancer Treatment and Research (28 papers) and Advanced Radiotherapy Techniques (20 papers). Himanshu Nagar collaborates with scholars based in United States, United Kingdom and India. Himanshu Nagar's co-authors include Silvia C. Formenti, Paul J. Christos, Jim C. Hu, Christopher E. Barbieri, Sean S. Mahase, Elizabeth Mauer, Xian Wu, Josephine Kang, Xiaoyue Ma and Mark L. Entman and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Himanshu Nagar

64 papers receiving 721 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Himanshu Nagar United States 15 318 196 189 180 159 71 728
Weisi Yan United States 12 270 0.8× 158 0.8× 122 0.6× 317 1.8× 169 1.1× 30 652
Fabiana Gregucci Italy 17 287 0.9× 197 1.0× 114 0.6× 178 1.0× 218 1.4× 46 631
Tithi Biswas United States 18 517 1.6× 243 1.2× 109 0.6× 378 2.1× 301 1.9× 101 1.0k
D.N. Yeboa United States 16 476 1.5× 171 0.9× 125 0.7× 279 1.6× 156 1.0× 86 936
Gianpiero Catalano Italy 17 455 1.4× 158 0.8× 251 1.3× 442 2.5× 197 1.2× 41 941
Cinzia Iotti Italy 20 487 1.5× 352 1.8× 95 0.5× 182 1.0× 379 2.4× 80 953
Valentina Lancellotta Italy 18 182 0.6× 193 1.0× 170 0.9× 332 1.8× 170 1.1× 105 913
Astrid N. Scholten Netherlands 19 230 0.7× 196 1.0× 280 1.5× 286 1.6× 219 1.4× 58 1.0k
Talha Shaikh United States 15 528 1.7× 160 0.8× 151 0.8× 288 1.6× 205 1.3× 43 947
Eleonor Rivin del Campo France 19 275 0.9× 151 0.8× 95 0.5× 222 1.2× 190 1.2× 83 1.0k

Countries citing papers authored by Himanshu Nagar

Since Specialization
Citations

This map shows the geographic impact of Himanshu Nagar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Himanshu Nagar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Himanshu Nagar more than expected).

Fields of papers citing papers by Himanshu Nagar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Himanshu Nagar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Himanshu Nagar. The network helps show where Himanshu Nagar may publish in the future.

Co-authorship network of co-authors of Himanshu Nagar

This figure shows the co-authorship network connecting the top 25 collaborators of Himanshu Nagar. A scholar is included among the top collaborators of Himanshu Nagar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Himanshu Nagar. Himanshu Nagar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jade, Jim C. Hu, Yuliya Jhanwar, et al.. (2024). Reasons for Discordance between 68Ga-PSMA-PET and Magnetic Resonance Imaging in Men with Metastatic Prostate Cancer. Cancers. 16(11). 2056–2056. 1 indexed citations
2.
Howard, Lauren E., Bridget F. Koontz, Scott T. Tagawa, et al.. (2024). Intensifying Salvage Therapy in Prostate-specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy with Apalutamide, Salvage Radiation, and Docetaxel: The Phase 2 STARTAR Trial. European Urology Oncology. 8(2). 287–295. 1 indexed citations
3.
Villa-Pulgarín, Janny A., Francesca Khani, Jian Wu, et al.. (2024). Radiation-Induced TREM2-Expression on Tumor-Associated Macrophages Is a Target for Modulation of Immune Responses in Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 120(2). S98–S98.
4.
Ballman, Karla V., Ariel E. Marciscano, Christopher E. Barbieri, et al.. (2024). Radiation therapy and IRreversible electroporation for intermediate risk prostate cancer (RTIRE). BMC Urology. 24(1). 151–151. 2 indexed citations
5.
Nagar, Himanshu, Xi Kathy Zhou, Christopher E. Barbieri, et al.. (2024). 1974: Acute Toxicity in a Randomized Trial of MRI-guided Salvage RT for Prostate Cancer in 4 vs. 2 Weeks. Radiotherapy and Oncology. 194. S2478–S2479.
6.
Lui, Asona, Matthew S. Katz, Alejandro Berlín, et al.. (2023). Use of Focal Radiotherapy Boost for Prostate Cancer and Perceived Barriers toward its Implementation: A Survey. International Journal of Radiation Oncology*Biology*Physics. 117(2). e454–e455. 2 indexed citations
7.
8.
Marciscano, Ariel E., Xi Kathy Zhou, Christopher E. Barbieri, et al.. (2023). Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER). BMC Cancer. 23(1). 781–781. 6 indexed citations
9.
Martínez, J Gil, Jana Ivanidze, Himanshu Nagar, et al.. (2023). Complex implementation factors demonstrated when evaluating cost-effectiveness and monitoring racial disparities associated with [18F]DCFPyL PET/CT in prostate cancer men. Scientific Reports. 13(1). 8321–8321. 8 indexed citations
10.
Kim, Heejong, Daniel Margolis, Himanshu Nagar, & Mert R. Sabuncu. (2022). Pulse Sequence Dependence of a Simple and Interpretable Deep Learning Method for Detection of Clinically Significant Prostate Cancer Using Multiparametric MRI. Academic Radiology. 30(5). 966–970. 6 indexed citations
11.
Basourakos, Spyridon P., et al.. (2022). Evolving Trends in the Management of Low-Risk Prostate Cancer. Clinical Genitourinary Cancer. 20(5). 423–430. 2 indexed citations
12.
Agrawal, Vishesh, Xiaoyue Ma, Jim C. Hu, Christopher E. Barbieri, & Himanshu Nagar. (2022). Trends in Androgen Deprivation Use in Men With Intermediate-Risk Prostate Cancer Who Underwent Radiation Therapy. Advances in Radiation Oncology. 7(4). 100904–100904. 4 indexed citations
13.
Nagar, Himanshu & Daniel E. Spratt. (2021). Prostate SBRT Dose Escalation (9 Gy × 5, 13.3 Gy × 3, 24 Gy × 1): Are We Making Progress?. International Journal of Radiation Oncology*Biology*Physics. 111(1). 110–112. 1 indexed citations
14.
Chuong, Michael D., Mary Ann Clark, Lauren E. Henke, et al.. (2021). Patterns of Utilization and Clinical Adoption of 0.35 MR-Guided Radiation Therapy in the United States — Understanding the Transition to Adaptive, Ultra-Hypofractionated Treatments. International Journal of Radiation Oncology*Biology*Physics. 111(3). e510–e510. 4 indexed citations
15.
Ma, Xiaoyue, et al.. (2020). Trends And Disparities In The Diagnosis And Initial Management Of High-Risk Prostate Cancer In The United States. International Journal of Radiation Oncology*Biology*Physics. 108(3). e867–e868. 2 indexed citations
16.
Chen, Jonathan, Xian Wu, Paul J. Christos, Silvia C. Formenti, & Himanshu Nagar. (2018). Practice patterns and outcomes for patients with node-negative hormone receptor-positive breast cancer and intermediate 21-gene Recurrence Scores. Breast Cancer Research. 20(1). 26–26. 5 indexed citations
17.
Mann, J.M., Xian Wu, Paul J. Christos, et al.. (2016). National Practice Patterns of Axillary Management and Adjuvant Radiation After ACOSOG Z0011. International Journal of Radiation Oncology*Biology*Physics. 96(2). E32–E32.
18.
Mauer, Elizabeth, et al.. (2016). Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non–Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database. Journal of Thoracic Oncology. 12(2). 302–313. 49 indexed citations
19.
Nagar, Himanshu, Lili Zhou, Cristina Sison, et al.. (2013). Is There a Tradeoff in Using Modified High Tangent Field Radiation for Treating an Undissected Node-Positive Axilla?. Clinical Breast Cancer. 14(2). 109–113. 9 indexed citations
20.
Nagar, Himanshu, Dustin Boothe, M. Yondorf, et al.. (2013). Administration of Concurrent Vaginal Brachytherapy During Chemotherapy for Treatment of Endometrial Cancer. International Journal of Radiation Oncology*Biology*Physics. 87(4). 665–669. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weisi Yan Breakdown of academic impact, for papers by Fabiana Gregucci Breakdown of academic impact, for papers by Tithi Biswas Breakdown of academic impact, for papers by D.N. Yeboa Breakdown of academic impact, for papers by Gianpiero Catalano Breakdown of academic impact, for papers by Cinzia Iotti Breakdown of academic impact, for papers by Valentina Lancellotta Breakdown of academic impact, for papers by Astrid N. Scholten Breakdown of academic impact, for papers by Talha Shaikh Breakdown of academic impact, for papers by Eleonor Rivin del Campo
Rankless by CCL
2026